423
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Nebivolol Ameliorates Hepatic Ischemia/Reperfusion Injury on Liver But Not on Distant Organs

, , , , , , & show all
Pages 245-252 | Received 30 Dec 2014, Accepted 17 Mar 2015, Published online: 25 Aug 2015

REFERENCES

  • Rahbari NN, Wente MN, Schemmer P, et al. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg 2008;95:424–432.
  • Smyrniotis V, Farantos C, Kostopanagiotou G, et al.Vascular control during hepatectomy: review of methods and results. World J Surg 2005;29:1384–1396.
  • Sehirli O, Ozel Y, Dulundu E, et al. Grape seed extract treatment reduces hepatic ischemia–reperfusion injury in rats. Phytother Res 2008;22:43–48.
  • Arab HA, Sasani F, Rafiee MH, et al. Histological and biochemical alterations in early-stage lobar ischemia–reperfusion in rat liver. World J Gastroenterol 2009;15:1951–197.
  • Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011;26(Suppl 1):173–179.
  • Behrends M, Hirose R, Park YH, et al. Remote renal injury following partial hepatic ischemia/reperfusion injury in rats. J Gastrointest Surg 2008 Mar;12(3):490–495.
  • Nielsen VG, Tan S, Baird MS, et al. Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia-reperfusion. Crit Care Med 1997;25:1044–1050.
  • Peralta C, Perales JC, Bartrons R, et al. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia–reperfusion. Am J Pathol 2002;160:2111–2122.
  • Jiang H, Meng F, Li W, et al. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 2007;141:32–40.
  • Oguz A, Kapan M, Onder A, et al. The effects of curcumin on the liver and remote organs after hepatic ischemia reperfusion injury formed with Pringle manoeuvre in rats. Eur Rev Med Pharmacol Sci 2013 ;17:457–466.
  • Kapan M, Gumus M, Onder A, et al. The effects of ellagic acid on the liver and remote organs’ oxidative stress and structure after hepatic ischemia reperfusion injury caused by pringle maneuver in rats. Bratisl Lek Listy 2012;113:274–281.
  • Boyuk A, Onder A, Kapan M, et al. Ellagic acid ameliorates lung injury after intestinal ischemia–reperfusion. Pharmacogn Mag 2011;7:224–228.
  • Celebi F, Yilmaz I, Aksoy H, et al. Dehydroepiandrosterone prevents oxidative injury in obstructive jaundice in rats. J Int Med Res 2004;32:400–405.
  • Serracino-Inglott F, Virlos IT, Habib NA, et al. Differential nitric oxide synthase expression during hepatic ischemia–reperfusion. Am J Surg 2003;185:589–595.
  • Phillips L, Toledo AH, Lopez-Neblina F, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg 2009;22:46–55. doi: 10.1080/08941930802709470.
  • Rozec B, Gauthier C. Beta3-adrenoceptors in the cardiovascular system: putative roles in human pathologies. Pharmacol Ther 2006;111:652–673.
  • Toblli JE, DiGennaro F, Giani JF, et al. Nebivolol: impact on cardiac and endothelial function and clinical utility. Vasc Health Risk Manag 2012;8:151–160.
  • Soydan G, Cekic EG, Tuncer M. Nebivolol has protective effect against endothelial and ileal dysfunction due to I/R. J Surg Res 2011;166:156–161.
  • Uzar E, Acar A, Evliyaoğlu O, et al. The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia/reperfusion in rats. Prog Neuropsychopharmacol Biol Psych 2012;36:22–28. doi: 10.1016/j.pnpbp.2011.08.011. Epub 2011 Aug 23.
  • Ulger BV, Kapan M, Uslukaya O, et al. Comparing the effects of nebivolol and dexpanthenol on wound healing: an experimental study. Int Wound J 2014. doi: 10.1111/iwj.12314. [Epub ahead of print]
  • Sanaee F, Valente Neves D, Lanchote VL, et al. Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity. Biopharm Drug Dispos 2013;34(6):312–320. doi: 10.1002/bdd.1847.
  • Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103.
  • Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119.
  • Camargo Jr CA, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997;26:1513–1520.
  • Koksel O, Yildirim C, Cinel L, et al. Inhibition of poly (ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia reperfusion in rats. Pharmacol Res 2005;51:453–462.
  • Chatterjee PK, Cuzzocrea S, Brown PA, et al. Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 2000;58:658–673.
  • Chattopadhyay P, Verma N, Verma A, et al. L-arginine protects from pringle manoeuvre of ischemia–reperfusion induced liver injury. Biol Pharm Bull 2008;31:890–892.
  • Chen YW, Li CH, Zhang AQ, et al. Preserving hepatic artery flow during portal triad blood inflow occlusion reduces liver ischemia–reperfusion injury in rats. J Surg Res 2012;174:150–156.
  • Park SW, Chen SW, Kim M, et al. Human activated protein C attenuates both hepatic and renal injury caused by hepatic ischemia and reperfusion injury in mice. Kidney Int 2009;76:739–750.
  • Miranda LE, Capellini VK, Reis GS, et al. Effects of partial liver ischemia followed by global liver reperfusion on the remote tissue expression of nitric oxide synthase: lungs and kidneys. Transplant Proc 2010;42:1557–1562.
  • Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia–reperfusion injury. Am J Surg 2001;181:160–166.
  • Vollmar B, Glasz J, Leiderer R, et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia–reperfusion. Am J Pathol 1994;145:1421–1431.
  • Jaeschke H. Molecular mechanisms of hepatic ischemia–reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003;284:G15–G26.
  • Menger MD, Richter S, Yamauchi J, et al. Role of microcirculation in hepatic ischemia/reperfusion injury. Hepatogastroenterology 1999;46:1452–1457.
  • Rüdiger HA, Graf R, Clavien PA. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003;16:149–159.
  • Kohli V, Selzner M, Madden JF, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia–reperfusion injury in the rat liver. Transplantation 1999;67:1099–1105.
  • Nastos C, Kalimeris K, Papoutsidakis N, et al. Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev 2014;2014:906965. doi: 10.1155/2014/906965.
  • Onder A, Kapan M, Gumus M, et al. The protective effects of curcumin on intestine and remote organs against mesenteric ischemia/reperfusion injury. Turk J Gastroenterol 2012;23:141–147.
  • Yildirim A, Gumus M, Dalga S, et al. Dehydroepiandrosterone improves Ehepatic antioxidant systems after renal ischemia–reperfusion injury in rabbits. Ann Clin Lab Sci 2003;33:459–464.
  • Gul M, Aliosmanoglu I, Uslukaya O, et al. The protective effect of ellagic acid on lung damage caused by experimental obstructive jaundice model. Acta Chir Belg 2013;113:285–289.
  • Gumus M, Tekin R, Firat U, et al. The effects of pomegranate on bacterial translocation in rats with obstructive jaundice. Eur Rev Med Pharmacol Sci 2013;17:1488–1494
  • Gumuş M, Yuksel H, Evliyaoglu O, et al. Effects of ellagic acid on copper, zinc, and biochemical values in serum and liver of experimental cholestatic rats. Biol Trace Elem Res 2011;143:386–393.
  • Gul M, Cömert M, Çakmak GK, et al. Effect of erythropoietin on liver regeneration in an experimental model of partial hepatectomy. Int J Surg 2013;11:59–63.
  • Datta G, Fuller BJ, Davidson BR. Molecular mechanisms of liver ischemia reperfusion injury: insights from transgenic knockout models. World J Gastroenterol 2013;19: 1683–1698.
  • Rivera-Chavez FA, Toledo-Pereyra LH, Dean RE, et al. Exogenous and endogenous nitric oxide but not iNOS inhibition improves function and survival of ischemically injured livers. J Invest Surg 2001;14:267–273.
  • Hines IN, Kawachi S, Harada H, et al. Role of nitric oxide in liver ischemia and reperfusion injury. Mol Cell Biochem 2002;234–235:229–237.
  • Abe Y, Hines IN, Zibari G, et al. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med 2009;46:1–7.
  • Duranski MR, Elrod JW, Calvert JW, et al. Genetic overexpression of eNOS attenuates hepatic ischemia–reperfusion injury. Am J Physiol Heart Circ Physiol 2006;291:2980–2986.
  • Kukreja RC, Salloum F, Das A, et al. Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol 2005;42:219–232.
  • Lee HT, Park SW, Kim M, et al. Acute kidney injury after hepatic ischemia and reperfusion injury in mice. Lab Invest 2009;89:196–208.
  • Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. Liver Transpl 2002;8:91–109.
  • Ota S, Nakamura K, Yazawa T, et al. High tidal volume ventilation induces lung injury after hepatic ischemia–reperfusion. Am J Physiol Lung Cell Mol Physiol 2007;292:625-631.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.